Friday, August 11, 2017

New anti-inflammatory drug reduces death of existing brain cells then repairs damage after stroke

›
Researchers at The University of Manchester have discovered that a potential new drug reduces the number of brain cells destroyed by st...
3 comments:
Thursday, August 10, 2017

Walnuts could be key to happier state-of-mind in young healthy men

›
In continuation of my update on walnuts College can be a stressful time for young adults as they figure out how to manage intense...
Wednesday, August 9, 2017

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

›
The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular d...

Arthritis drug increases effectiveness of antidepressants in bipolar patients

›
In continuation of my updates on celecoxib Giving severely depressed patients the arthritis drug celecoxib (Celebrex®) dramatically ...
Sunday, August 6, 2017

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

›
In efforts to develop new treatments for brain cancer, scientists from Johns Hopkins Drug Discovery and the Kimmel Cancer Center's Blo...
Saturday, August 5, 2017

U.S. FDA panel narrowly backs Cempra's antibiotic solithromycin

›
A panel of federal health advisers has narrowly recommended approval for an experimental antibiotic from Cempra Inc., a small North Caroli...
Thursday, August 3, 2017

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

›
A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a com...
Wednesday, August 2, 2017

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

›
A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a com...
Tuesday, August 1, 2017

Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia

›
Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leuk...
Monday, July 31, 2017

Cranberry extract disrupts communication between bacteria linked to pervasive infections

›
In continuation of my update on cranberry Scientists from McGill University and INRS-Institut Armand-Frappier in Canada recently relea...
Sunday, July 30, 2017

New drug appears to decrease inflammation in the brain linked to Alzheimer's disease

›
An experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in ...
Thursday, July 27, 2017

FDA approves new therapy for initial treatment of soft tissue sarcoma

›
In continuation of my update on  Doxorubicin The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (ola...
Wednesday, July 26, 2017

New clinical study to examine novel dietary approach for TNBC

›
A new clinical trial for women with clinically aggressive triple-negative breast cancer (TNBC) will test a novel theory: Will a diet low i...
Monday, July 24, 2017

Folinic acid treatment could help improve language and communication skills of children with ASD

›
In continuation of my update on Folinic acid Prescription doses of folinic acid, which is a reduced form of a B vitamin known as folat...
Sunday, July 23, 2017

Study on common bacterium presents new pathway to combat gastric cancers

›
A common bacterium that more than half of people have in their gut can use hydrogen gas present in the gastrointestinal tract to inject a ...